Table 1.
Characteristics | Patients (n) |
---|---|
Clinical Stage: | |
T3 | 130 |
T2c | 158 |
T2b | 20 |
T2a | 10 |
T1c | 3 |
| |
Gleason: | |
7 | 218 |
8 | 32 |
9-10 | 18 |
| |
PSA: | |
0–10 | 141 |
10–20 | 116 |
>20 | 64 |
Characteristics | Patients (n) |
---|---|
Clinical Stage: | |
T3 | 130 |
T2c | 158 |
T2b | 20 |
T2a | 10 |
T1c | 3 |
| |
Gleason: | |
7 | 218 |
8 | 32 |
9-10 | 18 |
| |
PSA: | |
0–10 | 141 |
10–20 | 116 |
>20 | 64 |